Transition cow health and immune function

Similar documents
Erika K. Ganda 1, Natalia Gaeta 2, Anja Sipka 1, Brianna Pomeroy 1, Georgios Oikonomou 1,3, Ynte H. Schukken 1,4,5 and Rodrigo C.

THE BOVINE MILK MICROBIOME. Mark McGuire

Mastitis: Background, Management and Control

Gina M Pighetti & Raul Almeida. University of Tennessee

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

Update on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia

New Developments in Mastitis Research

MILK COMPOSITIONAL CHANGES DURING MASTITIS

Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.

Proper Dry-Off Procedures to Prevent New Infections and Cure Existing Cases of Mastitis. Stephen C. Nickerson University of Georgia

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

MASTITIS CASE MANAGEMENT

Evaluation of intervention strategies for subclinical and clinical mastitis

Using SCC to Evaluate Subclinical Mastitis Cows

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

J. Dairy Sci. 90: doi: /jds American Dairy Science Association, 2007.

Milk quality & mastitis - troubleshooting, control program

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Interpretation of Bulk Tank Milk Results

Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Quality Milk on Pasture Based Dairy Farms. Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle

Cepravin and Combination Dry Cow Therapy Trial Work

MASTITIS. Therefore, mastitis is an inflammation of the mammary gland.

Northern NY Agricultural Development Program 2016 Project Report

How to Decrease the Use of Antibiotics in Udder Health Management

Milk Quality Management Protocol: Fresh Cows

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

MATERIALS AND METHODS

S. P. Oliver, R. A. Almeida, B. E. Gillespie, S. J. Ivey, H. Moorehead, P. Lunn, H. H. Dowlen, D. L. Johnson, and K. C. Lamar

IMMUNOSTIMULATING EFFECTS OF A COMMERCIAL FEED SUPPLEMENT IN DAIRY HEIFERS VACCINATED WITH A STAPHYLOCOCCUS AUREUS BACTERIN VALERIE JOANNE EUBANKS

Heifer Mastitis Management Strategies S.C. Nickerson, UGA,

Udder Health in an International Perspective

The mastitis situation in Canada where do you stand?

Interpretation of results from milk samples tested for mastitis bacteria with Mastit 4 qpcr test from DNA Diagnostic

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

Mastitis cows and immunization

MASTITIS PATHOGENS IN MILK OF DAIRY COWS IN SLOVAKIA

USING MANURE SOLIDS AS BEDDING Final Report. CORNELL WASTE MANAGEMENT INSTITUTE Ithaca, NY

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

TEAT DIP- POST DIP- PRE DIP- STRIPING

Management Practices and Intramammary Infections: New Ideas for an Old Problem

Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis in Dairy Cattle

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

Practical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Controlling Contagious Mastitis

LOOKING FOR PROFITS IN MILK QUALITY

Journal of Integrative Agriculture 2018, 17(6): Available online at ScienceDirect

Mastitis Management and SCC Control in Once a Day Herds. Don Crowley- Teagasc

MICROBIOLOGY of RAW MILK

Lactation. Macroscopic Anatomy of the Mammary Gland. Anatomy AS 1124

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

REPORT FROM THE. 3 rd GLOBAL MILK QUALITY EXPERT FORUM

Innovation in Mastitis Treatment

Understanding the Sources, Transmission Routes, and Prognoses for Mastitis Pathogens

CLINICAL MASTITIS PERCEPTIONS OF KANSAS DAIRY PRODUCERS. J.R. Roberson 1

Mastitis in non-bovine dairy species, companion animals and breastfeeding mothers. Chris Knight

CEVA products for reproduction management

Effect of omitting post-milking teat disinfection on the mastitis infection rate of dairy cows over a full lactation

Transition cows have decreased immune function. The transition period. Inflammation, Immune Function, and the Transition Cow.

Lactoferrin Concentrations in Milk from Normal and Subclinical Mastitic Cows

DRY YOUR BEST. The incidence and importance of milk leakage in the dry cow. Ana I. de Prado Corporate Technical Manager Ceva Santé Animale (France)

Mastitis Reminders and Resources LAURA SIEGLE EXTENSION AGENT VIRGINIA COOPERATIVE EXTENSION AMELIA COUNTY

Mastitis control in bred heifers: Use of dry cow therapy and teat sealant for curing existing intramammary infections and preventing new ones

Evaluation of a new qpcr test to specify reasons behind total bacterial count in bulk tank milk

Strep. ag.-infected Dairy Cows

On- farm milk culture training workshop

The organism Infection process Tissue reaction SCC response Prevention Treatment

Mastitis Module Risk Assessment Guide by Pathogen. Streptococcus agalactiae

Quality Milk. got milk? Milk Quality. Why Bacteria in Milk Matters. Bacteria in Milk. Milk.One of Mother Nature s Most Perfect Foods

MILK QUALITY PROGRAMS FOR TRANSITION COWS AND HEIFERS. Leo Timms Iowa State University, Ames IA

J. Dairy Sci. 94 : doi: /jds American Dairy Science Association, 2011.

On-farm milk culture training workshop. Christina Petersson-Wolfe Department of Dairy Science Virginia Tech

MASTITIS DNA SCREENING

Institut for Produktionsdyr og Heste

Options for Handling Mastitis during Lactation in Modern Dairy Farms

LOCAL TOLERANCE OF INTRAMAMMARY PREPARATIONS IN COWS

Prevention of clinical and subclinical mastitis

Analysis of the microbial population that most often causes mastitis in dairy cows

Bulk Milk Data and Udder Health

Managing Mastitis in Dairy Heifers to Improve Overall Herd Health

Low Somatic Cell Count: a Risk Factor for Subsequent Clinical Mastitis in a Dairy Herd

Genetic parameters for pathogen specific clinical mastitis in Norwegian Red cows

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

TREATMENT DECISIONS FOR MILD AND MODERATE CASES OF CLINICAL MASTITIS. Carolina Pinzón-Sánchez

Key words: mastitis, dairy, fertility, animal reproduction

The Bimeda Guide to Selective Dry Cow Therapy

Milk Quality Evaluation Tools for Dairy Farmers

Case Study: Dairy farm reaps benefits from milk analysis technology

Edinburgh Research Explorer

MICROBIOTA DEL LATTE E BIODIVERSITA

Quad Plate User s Manual

The use of the dry cow therapy in the control of bovine mastitis

Transcription:

Transition cow health and immune function Ynte Schukken, Brianna Pomeroy and Anja Sipka Cornell University Wageningen University Utrecht University GD Animal Health

Introduction Transition cow health: Transition from lactation to dry Transition form dry to lactation Transition from healthy to diseased Transition from diseased to healthy Resilience Mammary microbiome Immune responsiveness

What is milk microbiome? Microbial populations as found using next generation sequencing or pyro-sequencing. Population of bacterial species identified using 16S sequencing of bacterial DNA isolated from milk Approximately 7000 bacterial 16S sequences corresponding to ~1000 bacterial species per milk sample (1 ml), and likely more in milk from healthy quarters.

Number species in milk Mammary microbiome Healthy Quarters T. pyogenes Mastitis quarters Number of sequences in milk Oikonomou et al. 2014

T. pyogenes+ samples % of sequences 1 Arcanobacterium 0.9 0.8 0.7 Porphyromonas 0.6 0.5 0.4 0.3 Fusobacterium 0.2 0.1 0 1 2 3 Oikonomou et al. 2016

SCC <20 aerobic culture negative 80 % of identified sequences 70 60 50 40 30 20 10 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Oikonomou et al. 2016

S. uberis+ samples 1 % of identified sequences Streptococcus 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Fusobacterium Genera level results: Culture-negative mastitis samples Asticcacaulus 1 0.9 % of identified sequences 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 1 2 3 4 5 6 7 8 9 1011 121314 1516 171819 2021 222324 252627 2829 303132 3334 353637 3839

Culture Negative CM samples versus SCC <10K 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% % of identified sequences 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 80 70 60 50 40 30 20 10 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Self vs non-self Gensollen et al. 2016

Farm specific mammary eco system Farm I Farm II Contributing: anaerococcus, streptococcus, propionibacter,..

Is there a resilient microbiome? Patho-gen Non-gen Physio-gen Sphingobacterium Streptococcus Paenibacillus Anaerococcus

Ecologic resilience Scheffer et al. 1993

Challenge infection - E. coli - LV RV Control LA RA Challenge Control Antibiotics Ganda et al. 2017

100% 50% 0% 100% 50% 0% 100% 50% 0% 100% 50% 0% -72-60 -48-36 -24-12 0 6 12 18 24 30 36 42 48 54 60 72 78 84 96 102108120126132144150156168174180192198204216 Time (hours) Ruminococcaceae Enterobacteriaceae Aerococcaceae Lachnospiraceae Corynebacteriaceae Planococcaceae Bacillaceae Clostridiaceae Bacteroidaceae Staphylococcaceae Micrococcaceae Paraprevotellaceae Pseudomonadaceae Succinivibrionaceae Spirochaetaceae Prevotellaceae Rikenellaceae Xanthomonadaceae Veillonellaceae Streptococcaceae Fusobacteriaceae Peptostreptococcaceae Weeksellaceae S24-7 Comamonadaceae Other

Treatments Challenge infection - E. coli - 80 70 60 50 Enterobacter (%) E. coli challenge * * * * * * * * 40 30 20 10 0-72 -60-48 -36-24 -12 0 12 24 36 48 60 72 84 96 108120132144156168180192204216

Treatments Challenge infection - E. coli - 10 9 Shannon Index of diversity E. coli challenge Challenged, Non-Treated Challenged, Treated 8 7 6 * * * * 5 4 3 2 1 0-72 -60-48 -36-24 -12 0 12 24 36 48 60 72 84 96 108 120 132 144 156 168 180 192 204 216

Antibiotics in healthy quarters 10 9 8 Shannon Index of Diversity Not challenged, not treated Not challenged, treated 7 6 5 4 3 2 Treatments 1 0-72 -60-48 -36-24 -12 0 12 24 36 48 60 72 84 96 108120132144156168180192204216

Intramammary resilience Scheffer et al. 2001

Microbial eco-systems Take home messages The mammary gland of dairy cows harbors a microbial ecosystem. Potential for a resilient ecosystem Intramammary challenge results in a loss of bacterial diversity. Some cows are more resilient to exotic bacterial growth compared to other more susceptible cows. Immediate appropriate antibacterial treatment results in a reduced loss of diversity.

Dry period immunobiology Minor Staph. Strep. E. coli IMI in late gestation No IMI in late gestation Green et al. 2002

Challenge in late gestation: E. coli Parturition 100 cfu E. coli Quesnell et al. 2012

Pro-inflammatory Cytokine Il-1 : no response Calving Days after challenge 100 cfu E. coli Clinical mastitis challenge strain Quesnell et al. 2012

IL-4 (ng/ml) Anti-inflammatoire Cytokine response: IL-4 0.5 0.45 0.4 0.35 0.3 0.25 0.2 0.15 0.1 0.05 100 cfu E. coli 0-14 -12-10 -8-6 -4-2 0 2 4 6 8 10 12 14 16 12 hour periods relative to challenge Gurjar et al. 2013

Pro-inflammatory response Cytokine: IL-1 Mid-lactation Hours post challenge 100 cfu E. coli Sipka et al. 2013

Th1:Th2 ratio Mid-lactation Post-partum Late gestation

Improve immune response Innate: Teat-end quality Lactoferrin NEB Immune modulation: Selenium/vitamin E Cytokines Adaptive: Vaccination E. coli & S. aureus & other Imm immunostimulation

Incidence Clinical Mastitis Bovine Granulocyte Colony Stimulating Factor (rbg-csf) 40% 35% 30% 25% 20% 15% 10% 5% 0% Saline 5 μg/kg 10 μg/kg 20 μg/kg Dose Peg - BGCSF Treatment N N % mastitis Duration Severity cows mastitis Saline 53 18 34% 10.8 2,95 5 μg/kg 51 10 20% 5.3 3,2 10 μg/kg 54 9 17% 8.4 3,3 20 μg/kg 53 5 9% 6.9 3 Hassfurther et al. 2015

E. coli vaccination reduces severity 32 E. coli challenge study 30 Milk Production (Kg) 28 26 24 22 20 Control Vaccinated ~ 50% reduced production loss 18-6 -4-2 0 2 4 6 8 10 Days relative to challenge Wilson et al. 2006

N=10 N=5 Intramammary immunization with Days -44, UV IR E. coli -30, -16 Vaccine J5 Bacterin N=10 Day -30 LF LH RF RH IMM sensitization w/ equivalent 100 cfu E. coli C1 Days -44, -30, -16 Day -30 Vaccine J5 Bacterin N=5 LF RF LH RH Day 0 immuniza IMM sensitization w/ tion w/ equivalent 100 cfu E. coli C1 Control N=5 IMM challenge w/ 100 cfu/ml E. coli C1 Control blank IMM sensitization immunization Control PBS IMM challenge Day 0 IMM challenge w/ 100 cfu/ml E. coli C1 Control blank Pomeroy et al. 2016

Probability of having IMI Log 10 (CFU+1) Intramammary immunization with UV irradiated E. coli 100 live CFU P -10d Parturition Control Immunized 100 CFU UV IR E. coli Pomeroy et al. 2016

Pregnancy and Immune response Immune response in late gestation: anti-inflammatory IL-4 spike No pro-inflammatory response after challenge Immune response changes from late gestation to early lactation: From anti-inflammatory to pro-inflammatory Infection in late gestation but clinical response in early lactation..

Ecologic resilience in transitions Scheffer et al. 1993

Take home message Mammary microbiome High diversity is important Resilient microbiome is likely Farm specific Treatment affects microbiome Immune responsiveness Late gestation affects immune bias Systemic and local immune response may be improved Resilient system prevents infection and disease